Submitted:
04 January 2024
Posted:
04 January 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study design:
2.2. Search methods:
2.3. Data extraction:
2.4. Synthesis of the results:
Risk of Bias:
3. Results
3.1. Characteristics of interventions
3.2. Impact of educational intervention on biomedical results
3.2.1. The impact of educational intervention on HbA1c levels (Table 5)
| Studies general information | Baseline | Post intervention | Change | Absolute effect | |||
|---|---|---|---|---|---|---|---|
| IG | CG | IG | CG | IG | CG | ||
| [21] | 8.44±2.28 | 8.95±2.34 | 6.92±1.27* | 7.82±12.98*# | -1.52$ | -1.13 | -0.39 |
| [22] | 7.20(6.40, 9.10) | 7.90(6.80, 10.30) | 6.20(5.80, 6.60)* | 6.70(6.40, 7.30)* | -1** | -1.2 | +0.2 |
| [33] | 7.2(6.6-9.2) | 6.7(6.4-7.5) | 6.2(5.8-6.7)* | 6.4(5.8-6.8) | -1$ | -0.3 | -0.7 |
| [34] | 7.77±2.22 | No control group | 7.16±1.62 | No control group | -0.61*# | - | -0.61 |
| [27] | 9.5±2.1 | 9.5±2.0 | 7.4±1.5* | 9.5±2.1 | -2.1** | 0 | -2.1 |
| [29] | 5.95±0.47 | 5.95±0.47 | 5.14±0.36* | 5.85±0.37* | -0.81** | -0.1 | -0.71 |
| [25] | 6.66±1.09 | 6.86±1.34 | 5.85±0.37* | 6.97±1.18 | -0.81** | +0.11 | -0.70 |
| [35] | 7.85±1.19 | 7.32±1.23 | 6.66±0.84* | 6.95±1.31 | -1.19** | -0.37 | -0.82 |
| [31] | 6.5(6.2-7.0) | 6.6(6.3-7.1) | 6.6(6.3-7.1) | 6.7(6.3-7.1) | +0.1*# | +0.1 | 0 |
| [36] | 8.0(1.6) | - | 6.2(1.1)* | - | -1.8*# | - | -1.6±0.5 |
| [26] | 9.82±2.47 | 9.05±2.32 | 6.76±0.50* | 7.25±0.98* | -3.03** | -1.8 | -1.23 |
| [39] | 9.1±2.3 | - | 7.4±1.3* | - | -1.7±2.5* | - | -1.7±1 |
| Mean ±SD | -1.18±0.21 | -0.277±0.13 | 0.64±0.08 | ||||
3.2.2. The impact of educational intervention on FBG and PBG values (Table 6)
| Studies general information | Baseline | Post intervention | Change | Absolute effect | |||
|---|---|---|---|---|---|---|---|
| IG | CG | IG | CG | IG | CG | ||
| Effect of educational intervention on FBG | |||||||
| [22] | 8.00 | 8.00 | 6.78* | 7.70* | -1.22$ | -0.3 | -0.92 |
| [23] | 8.43±1.25 | 8.51±1.17 | 7.03±1.01* | 7.68±1.12 | -1.4** | -0.83 | -0.57 |
| [24] | 9.964±2.707 | 10.490±2.781 | 7.792±0.925* | 9.042±1.561 | -2.172** | -1.448 | -0.72 |
| [27] | 10.9±3.6 | 11.5±3.9 | 7.5±2.3* | 8.4±2.8* | -3.4** | -3.1 | -0.3 |
| [31] | 7.4 | 7.3 | 7.9 | 7.5 | +0.5**# | +0.2**# | +0.3 |
| [37] | 5.75 ± 1.01 | 6.55±1.76 | 5.66 ± 1.20 | 6.73 ± 2.66 | -0.09**# | +0.18 | 0.27 |
| Mean ±SD | -1.656±2.11 | -2.839±2.31 | -0.32±1.16 | ||||
| Effect of educational intervention on PBG | |||||||
| [22] | 13.29 | 12.67 | 7.90* | 10.58* | -5.39$ | -2.09 | -3.3 |
| [23] | 11.21±1.65 | 11.34±1.73 | 9.52±1.05* | 10.43±1.24 | -1.69** | -0.91 | -0.78 |
| [24] | 14.612±4.685 | 14.692±4.400 | 9.980±1.446* | 12.275±2.120 | -4.632** | -2.417 | -2.215 |
| [27] | 17.1±4.6 | 17.2±4.9 | 12.5±3.3* | 12.7±3.6* | -4.6**# | -4.5 | -0.1 |
| Mean ±SD | -4.078±2.35 | -2.479±2.41 | -1.598±0.23 | ||||
3.2.3. The impact of educational intervention on lipid profile
3.2.4. The impact of educational intervention on Anthropometric parameters (Table 7 - supplementary material)
3.2.5. The impact of educational intervention on Blood Pressure (Table 8 – supplementary material)
3.3. The impact of educational intervention on emotional and social results
3.4. The impact of educational intervention on behavioral results
3.5. Factors affecting glucose control among newly diabetic patients with T2DM (Table 9-13 – supplementary material)
4. Discussion
5. Conclusions
6. Implications of health care personnel and patients:
Supplementary Materials
Author Contributions
Funding
Conflicts of Interest
References
- J. A. da Silva, E. C. F. de Souza, A. G. Echazú Böschemeier, C. C. M. da Costa, H. S. Bezerra, and E. E. L. C. Feitosa, ‘Diagnosis of diabetes mellitus and living with a chronic condition: participatory study’, BMC Public Health, vol. 18, no. 1, p. 699, Jun. 2018. [CrossRef]
- Internationa Diabetes Federation, ‘IDF Atlas 10th Edition’, 10th Edition, 2021. Accessed: Oct. 10, 2022. [Online]. Available: https://diabetesatlas.org/idfawp/rwsource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf.
- M. K. Ali, J. Pearson-Stuttard, E. Selvin, and E. W. Gregg, ‘Interpreting global trends in type 2 diabetes complications and mortality’, Diabetologia, vol. 65, no. 1, pp. 3–13, Jan. 2022. [CrossRef]
- S. Chatterjee, K. Khunti, and M. J. Davies, ‘Type 2 diabetes’, Lancet, vol. 389, no. 10085, pp. 2239–2251, Jun. 2017. [CrossRef]
- A. Misra et al., ‘Diabetes in developing countries’, J Diabetes, vol. 11, no. 7, pp. 522–539, Jul. 2019. [CrossRef]
- WHO, ‘Global Report on Diabetes; World Health Organization’, Geneva, 2016. [Online]. Available: iris.who.int/bitstream/handle/10665/204871/9789241565257_eng.pdf?sequence=1.
- R. Rodriguez-Gutierrez et al., ‘Shared decision making in endocrinology: present and future directions’, Lancet Diabetes Endocrinol, vol. 4, no. 8, pp. 706–716, Aug. 2016. [CrossRef]
- K. Masuo, ‘Lifestyle Modification Is the First Line Treatment for Type 2 Diabetes’, in Type 2 Diabetes, K. Masuo, Ed., InTech, 2013. [CrossRef]
- A. Y. Y. Cheng and I. G. Fantus, ‘Oral antihyperglycemic therapy for type 2 diabetes mellitus’, CMAJ, vol. 172, no. 2, pp. 213–226, Jan. 2005. [CrossRef]
- M. Hanefeld, H. Fleischmann, T. Siegmund, and J. Seufert, ‘Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update’, Diabetes Ther, vol. 11, no. 8, pp. 1645–1666, Aug. 2020. [CrossRef]
- M. D. Adu, U. H. Malabu, A. E. O. Malau-Aduli, and B. S. Malau-Aduli, ‘Enablers and barriers to effective diabetes self-management: A multi-national investigation’, PLoS One, vol. 14, no. 6, p. e0217771, 2019. [CrossRef]
- M. A. Powers et al., ‘Diabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association’, Diabetes Care, vol. 43, no. 7, pp. 1636–1649, Jul. 2020. [CrossRef]
- K. D. Brunisholz et al., ‘Diabetes self-management education improves quality of care and clinical outcomes determined by a diabetes bundle measure’, J Multidiscip Healthc, vol. 7, pp. 533–542, 2014. [CrossRef]
- U. Ernawati, T. A. Wihastuti, and Y. W. Utami, ‘Effectiveness of diabetes self-management education (DSME) in type 2 diabetes mellitus (T2DM) patients: Systematic literature review’, J Public Health Res, vol. 10, no. 2, p. 2240, Apr. 2021. [CrossRef]
- Y. Yoshida et al., ‘Patient-specific factors associated with use of diabetes self-management education and support programs in Louisiana’, BMJ Open Diabetes Res Care, vol. 9, no. Suppl 1, p. e002136, Dec. 2021. [CrossRef]
- M. A. Powers et al., ‘Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics’, Clin Diabetes, vol. 34, no. 2, pp. 70–80, Apr. 2016. [CrossRef]
- A. L. Nguyen, E. Sepulveda, and M. Angulo, ‘It Feels Good to Know That Someone Cares’, Hisp Health Care Int, vol. 15, no. 2, pp. 52–57, Jun. 2017. [CrossRef]
- S. Taheri et al., ‘Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial’, Lancet Diabetes Endocrinol, vol. 8, no. 6, pp. 477–489, Jun. 2020. [CrossRef]
- M. J. Page et al., ‘The PRISMA 2020 statement: an updated guideline for reporting systematic reviews’, BMJ, p. n71, Mar. 2021. [CrossRef]
- J. P. T. Higgins et al., ‘The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials’, BMJ, vol. 343, no. oct18 2, pp. d5928–d5928, Oct. 2011. [CrossRef]
- D. Y. Chao, T. M. Lin, and W.-Y. Ma, ‘Enhanced Self-Efficacy and Behavioral Changes Among Patients With Diabetes: Cloud-Based Mobile Health Platform and Mobile App Service’, JMIR Diabetes, vol. 4, no. 2, p. e11017, May 2019. [CrossRef]
- S. Chai et al., ‘The effect of diabetes self-management education on psychological status and blood glucose in newly diagnosed patients with diabetes type 2’, Patient Educ Couns, vol. 101, no. 8, pp. 1427–1432, Aug. 2018. [CrossRef]
- X.-J. Jiang, ‘Influence of Orem’s self-care theory based “one-to-one” health education on self-management ability and quality of life in patients with newly diagnosed type 2 diabetes’, WCJD, vol. 26, no. 4, p. 282, 2018. [CrossRef]
- L. Wei, J. Wang, Z. Li, Y. Zhang, and Y. Gao, ‘Design and implementation of an Omaha System-based integrated nursing management model for patients with newly-diagnosed diabetes’, Prim Care Diabetes, vol. 13, no. 2, pp. 142–149, Apr. 2019. [CrossRef]
- X. Yu et al., ‘The effects of a nurse-led integrative medicine-based structured education program on self-management behaviors among individuals with newly diagnosed type 2 diabetes: a randomized controlled trial’, BMC Nurs, vol. 21, no. 1, p. 217, Aug. 2022. [CrossRef]
- Y. Hao and H. Xu, ‘A Prospective Cohort Study on the Management of Young Patients with Newly Diagnosed Type 2 Diabetes Using Mobile Medical Applications’, Diabetes Ther, vol. 9, no. 5, pp. 2099–2106, Oct. 2018. [CrossRef]
- R. Vinitha et al., ‘Effectiveness of mobile phone text messaging in improving glycaemic control among persons with newly detected type 2 diabetes’, Diabetes Res Clin Pract, vol. 158, p. 107919, Dec. 2019. [CrossRef]
- V. S. Parmar, S. V. Patel, and C. C. Iyer, ‘Effect of Counseling on Newly Diagnosed Type 2 Diabetes Mellitus Patients Visiting a Tertiary Care Hospital: A Randomized Control Trial’, Indian J Community Med, vol. 43, no. 3, pp. 244–245, 2018. [CrossRef]
- H. Kour, V. Kothiwale, and S. Goudar, ‘Impact of structured exercise therapy on impaired cognitive function among young adults diagnosed newly with type 2 diabetes mellitus – A randomized controlled trial’, Medical Journal of Dr. D.Y. Patil Vidyapeeth, vol. 13, p. 341, Jan. 2020. [CrossRef]
- L. Patnaik, S. K. Panigrahi, A. K. Sahoo, D. Mishra, A. K. Muduli, and S. Beura, ‘Effectiveness of Mobile Application for Promotion of Physical Activity Among Newly Diagnosed Patients of Type II Diabetes - A Randomized Controlled Trial’, Int J Prev Med, vol. 13, p. 54, 2022. [CrossRef]
- R. C. Vos, L. van Heusden, N. W. D. Eikelenboom, and G. E. H. M. Rutten, ‘Theory-based diabetes self-management education with pre-selection of participants: a randomized controlled trial with 2.5 years’ follow-up (ELDES Study)’, Diabet Med, vol. 36, no. 7, pp. 827–835, Jul. 2019. [CrossRef]
- A. L. van Puffelen, M. Rijken, M. J. W. M. Heijmans, G. Nijpels, F. G. Schellevis, and Diacourse study group, ‘Effectiveness of a self-management support program for type 2 diabetes patients in the first years of illness: Results from a randomized controlled trial’, PLoS One, vol. 14, no. 6, p. e0218242, 2019. [CrossRef]
- C. Colungo et al., ‘Health care and therapeutic education program for newly diagnosed type 2 diabetes: A new approach in primary care’, Endocrinol Diabetes Nutr (Engl Ed), vol. 65, no. 9, pp. 486–499, Nov. 2018. [CrossRef]
- S. Hernández-Jiménez, A. C. García-Ulloa, O. Y. Bello-Chavolla, C. A. Aguilar-Salinas, D. Kershenobich-Stalnikowitz, and Group of Study CAIPaDi, ‘Long-term effectiveness of a type 2 diabetes comprehensive care program. The CAIPaDi model’, Diabetes Res Clin Pract, vol. 151, pp. 128–137, May 2019. [CrossRef]
- E. Brusadelli, A. Tomasich, S. Bruno, A. Romanazzi, R. Dagani, and P. Porcelli, ‘Effects of Psychological Intervention in Glycemic Control of Patients with Type 2 Diabetes in Integrated Primary Care Setting’, Psychother Psychosom, vol. 87, no. 2, pp. 124–125, 2018. [CrossRef]
- T. K. Oser, M. Cucuzzella, M. Stasinopoulos, M. Moncrief, A. McCall, and D. J. Cox, ‘An Innovative, Paradigm-Shifting Lifestyle Intervention to Reduce Glucose Excursions With the Use of Continuous Glucose Monitoring to Educate, Motivate, and Activate Adults With Newly Diagnosed Type 2 Diabetes: Pilot Feasibility Study’, JMIR Diabetes, vol. 7, no. 1, p. e34465, Feb. 2022. [CrossRef]
- D. P. Bailey, L. H. Mugridge, F. Dong, X. Zhang, and A. M. Chater, ‘Randomised Controlled Feasibility Study of the MyHealthAvatar-Diabetes Smartphone App for Reducing Prolonged Sitting Time in Type 2 Diabetes Mellitus’, Int J Environ Res Public Health, vol. 17, no. 12, p. 4414, Jun. 2020. [CrossRef]
- O. P. Zaharia et al., ‘Improving insulin sensitivity, liver steatosis and fibrosis in type 2 diabetes by a food-based digital education-assisted lifestyle intervention program: a feasibility study’, Eur J Nutr, vol. 60, no. 7, pp. 3811–3818, Oct. 2021. [CrossRef]
- N. Yahia, M. Khoury, T. Salloum, R. Younes, M. Saleh, and E. Myers, ‘Implementing Evidence-Based Nutrition Practice Guidelines for Type 2 Diabetes Mellitus in Lebanon’, Top Clin Nutr, vol. 32, no. 4, pp. 316–329, Oct. 2017. [CrossRef]
- E. M. Mikhael, M. A. Hassali, and S. A. Hussain, ‘Effectiveness of Diabetes Self-Management Educational Programs For Type 2 Diabetes Mellitus Patients In Middle East Countries: A Systematic Review’, Diabetes Metab Syndr Obes, vol. 13, pp. 117–138, 2020. [CrossRef]
- R. Tanaka, T. Shibayama, K. Sugimoto, and K. Hidaka, ‘Diabetes self-management education and support for adults with newly diagnosed type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials’, Diabetes Res Clin Pract, vol. 169, p. 108480, Nov. 2020. [CrossRef]
- A. Steinsbekk, L. Ø. Rygg, M. Lisulo, M. B. Rise, and A. Fretheim, ‘Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis’, BMC Health Serv Res, vol. 12, p. 213, Jul. 2012. [CrossRef]
- M. J. Davies et al., ‘Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial’, BMJ, vol. 336, no. 7642, pp. 491–495, Mar. 2008. [CrossRef]
- American Diabetes Association, ‘Standards of Medical Care in Diabetes-2022 Abridged for Primary Care Providers’, Clin Diabetes, vol. 40, no. 1, pp. 10–38, Jan. 2022. [CrossRef]
- T. Katangwe, D. Bhattacharya, and M. J. Twigg, ‘A systematic review exploring characteristics of lifestyle modification interventions in newly diagnosed type 2 diabetes for delivery in community pharmacy’, Int J Pharm Pract, vol. 27, no. 1, pp. 3–16, Feb. 2019. [CrossRef]
- B. Chester, W. G. Stanely, and T. Geetha, ‘Quick guide to type 2 diabetes self-management education: creating an interdisciplinary diabetes management team’, Diabetes Metab Syndr Obes, vol. 11, pp. 641–645, 2018. [CrossRef]

| Inclusion criteria | Exclusion criteria | |
|---|---|---|
| Publication date | January 2017- November 2022 | <2017 |
| Study design | RCTs1and non-randomized controlled study, Intervention study, Cohort study. | Non-intervention studies2 |
| Population | Adult ≥18 years old diabetic patients Newly T2DM patients ≤ 5 years from diagnoses with type 2 diabetes |
Children, not newly T2DM patients ≥ 5 years from diagnoses with type 2 diabetes |
| Intervention | Different intervention used for health education. -Face to face intervention -Online intervention |
Drug based intervention |
| Control group | Standard care, routine care if it is present | |
|
Effectiveness Assessment |
-Biomedical results -Behaviour results -emotional and social results |
|
| Study duration | Any duration |
| Studies general information | Total number of participants Intervention group/ control group |
Demographic characteristic | Significant baseline Differences between groups |
Duration of diagnosis of diabetes | Settings |
|---|---|---|---|---|---|
| [21] 2019 China |
97 participants IG: 49CG: 48 |
Average age 63.71 years | No significant differences between groups | Type 2 DM (T2D) diagnosis received within the prior 3 months | Outpatient department |
| [22] 2018 China |
118 participants IG: 63 CG: 55 |
Mean age 54±11.5 | No significant differences between groups | Newly diagnosed type 2 diabetes | Outpatients and inpatients |
| [23] (2018) China |
106 patients IG(observation group): 53 CG: 53 |
mean age 58.62±15.74 years old | No significant difference between groups | Newly diagnosed T2DM Average duration of diabetes 1.24 years ± 0.35 years |
Hospitalized patients |
| [33] (2018) Spain |
271 participants IG: 134 CG: 137 |
IG 65.6±10.6 CG 67.5±13.5 |
Not clear | Newly diagnosed type 2 diabetes | Primary health centers |
| [24] (2019) China |
358 participants IG-179 CG-179 |
mean age of 50.1 ± 9.1 years | No significant difference between the two groups (P> 0.05) | Newly diagnosed type 2 diabetes | Outpatients department |
| [34] (2019) Mexico |
288 patients who had followed all the program No control group |
The mean age was 51.1 ± 10.3 years, 56.2% were women | Not clear | ≤5 years of diagnosis with T2DM | Outpatients department |
| [27] (2019) India | 248 participants IG = 126 CG= 122 |
The mean age was 43 ± 8.7 years 32.3% were woman |
No significant differences between groups | Newly diagnosed type 2 diabetes | Outpatients department |
| [28] (2018) India |
96 participants IG = 48 CG = 48 |
the age group from 25 to 65 years |
Not clear | Newly diagnosed type 2 diabetes | Medical outpatient department |
| [29] (2020) India | 136 participants IG = 66 CG=70 |
The mean age IG-37.2±4.09 CG-37.55±4.29 41.89% were female |
Not clear | Newly diagnosed type 2 diabetes | Medicine outpatient department |
| [25] (2022) China |
128 participants IG: 64 CG: 64 |
Average age 57.43 years 41.4% were female |
No significant differences between groups | Newly diagnosed type 2 diabetes (diagnosed in the preceding 3 to 9 months) | Primary healthcare services |
| [35] (2018) Italy |
95 participants IG: 47 CG: 48 |
Mean age 58.43±7.34 | No significant differences between groups | Newly diagnosed type 2 diabetes | Outpatient department |
| [31] (2019) Netherlands |
108 participants IG: 56 CG: 52 |
Mean age 62.3±7.8 | There were some differences between groups in the prevalence of diabetes-related complications. | Newly diagnosed type 2 diabetes (Diabetes duration of between 3 months and 5 years) | Outpatients department |
| [32] (2019) Netherlands |
137 participants IG: 62 CG: 75 |
Mean age 63.6 (10.2) | No significant differences between groups | Newly diagnosed type 2 diabetes (Diabetes duration of between 1-3 years) | Outpatients |
| [36] (2022) USA | 17 participants No control group |
mean age 52 years | Not clear | Newly diagnosed type 2 diabetes | Outpatients |
| [26] (2018) China |
126 participants IG: 66 CG: 60 |
Mean age 32.71±5.69 | No significant differences between groups | Newly diagnosed type 2 diabetes (the duration of disease was < 6 months) | Outpatients |
| [37] (2020) UK | 18 participants IG: 9 CG: 9 |
Mean age 56(6.5) F/M 50%/50% | No significant differences between groups | Newly diagnosed type 2 diabetes (T2DM diagnosed within the past 4 years (early stage) | Outpatients |
| [38] (2021) Germany |
24 participants No control group |
Mean age 56(6.5) F 58% | - | Newly diagnosed type 2 diabetes (Diabetes duration less than 4 years disease duration) | Outpatients |
| [39] (2017) Lebanon | 75 participants No control group |
Mean age 55±10.7 552% female |
- | Newly diagnosed type 2 diabetes | Diabetes outpatient clinics |
| [30] (2022) India |
66 participants IG= 33 CG=33 |
Mean age 42.29±9.5 66.66% Male |
No significant differences between groups | Newly diagnosed type 2 diabetes (within 3 months of diagnosis) | Endocrinology outpatient department |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).